Kalender
Markeder
Råvarer
Valuta
Lagre
Obligationer
Krypto
Indikatorer
Lande
Kalender
Markeder
Valuta
Lagre
Råvarer
Obligationer
Krypto
Indtjening
Ferie
Lande
Usa
Forenede Kongerige
Euroområdet
Australien
Canada
Japan
Kina
Brasilien
Rusland
Indien
Mere Lande
Indikatorer
Rentesats
Inflation-Rate
Arbejdsløshed Rate
Bnp-Vækst
Bnp Per Capita
Betalingsbalance
Guldreserver
Statsgældsforvaltningen
Crude Oil Produktion
Benzin Priser
Kreditvurdering
Mere Indikatorer
Prognoser
Lande
Indikatorer
Valuta
Lagre
Råvarer
Obligationer
Krypto
Apps
App Store
Google Play
Twitter
Seattle Genetics | Markedsværdi
Feedback
Market Capitalization
Lave om
Dato
AbbVie
USD 313.64B
40.03B
2024-03
Acadia Pharmaceuticals
USD 2.96B
2.18B
2024-03
Agios Pharmaceuticals
USD 1.68B
434M
2024-03
Amgen
USD 148.35B
5.79B
2024-03
Astellas Pharma
JPY 3.04T
709.27B
2023-12
Bayer
EUR 44.65B
4.92B
2023-09
Biogen
USD 31.4B
6.09B
2024-03
BioMarin Pharmaceutical
USD 15.87B
2.29B
2024-03
Bluebird Bio
USD 244M
19M
2024-03
Bristol-Myers Squibb
USD 105.66B
1.26B
2024-03
Celldex Therapeutics
USD 2.7B
535M
2024-03
Daiichi Sankyo
JPY 7.52T
473.2B
2023-12
Eisai
JPY 2.09T
376.18B
2023-12
Eli Lilly
USD 731.69B
178.32B
2024-03
Esperion Therapeutics
USD 340M
235M
2023-12
Exelixis
USD 7.26B
205M
2024-03
Genmab
DKK 142.73B
22.97B
2023-12
Gilead Sciences
USD 90.93B
10.01B
2024-03
GlaxoSmithKline
GBP 59.68B
1.42B
2023-12
Incyte
USD 12.89B
1.18B
2024-03
Insmed
USD 3.95B
486M
2024-03
Merck
USD 314.33B
38.07B
2024-03
Moderna
USD 40.08B
2.16B
2024-03
Nektar Therapeutics
USD 113M
4M
2023-09
Novartis
CHF 193.29B
20.5B
2023-12
Pfizer
USD 155.51B
7.05B
2024-03
Regeneron Pharmaceuticals
USD 106.74B
11.05B
2024-03
Sanofi
EUR 113.53B
14.8B
2023-12
Sarepta Therapeutics
USD 11.76B
2.73B
2024-03
Takeda
JPY 6.42T
928.65B
2023-12
Teva Pharmaceutical Industries
ILS 42.76B
315.46M
2023-12
Vertex Pharmaceuticals
USD 106.53B
1.68B
2024-03
Xencor
USD 1.37B
81M
2024-03
Seattle Genetics Markedsværdi - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Mar 2024.